Statins have shown to have some additional inhibitory effects on platelet aggregation and activation beyond lipid-independent mechanisms,42 potentially protecting against cardiovascular disease despite elevated levels of PCSK9. The gene discussed is PCSK9; the disease is cardiovascular disorder.